For instance, in ovarian, prostate, colorectal and hepatic cancers, as well as gliomas and leukemia, abnormal expression of PER1, PER2, PER3, CRY1, CRY2, BMAL1, CLOCK and NPAS2 are commonly seen [11,12,13,14]. This evidence concerns the gene BMAL1 and glioma.